Phillips 66 Responds to Glass Lewis and ISS Reports Phillips 66 today issued a comprehensive response challenging the recent recommendations from Institutional Shareholder Services (ISS) and Glass Lewis & Co. (Glass Lewis). The company expressed strong disagreement with the advisory…
Infleqtion and JPMorgan Chase Release Groundbreaking Open-Source Library for Quantum Error Correction A team of researchers from Infleqtion, in collaboration with JPMorgan Chase, has launched a new open-source research software library aimed at significantly accelerating advancements in quantum computing. This…
Nanotherm Partners with Battelle on Advanced Carbon Nanotube Heating Solutions Nanotherm, a leader in carbon-based thermal technologies, has announced a strategic collaboration with Battelle, a renowned research and development organization, to accelerate the creation of advanced heating solutions tailored for…
Proto Labs, Inc. Announces First Quarter 2025 Financial Results Proto Labs, a global leader in digital manufacturing services, has reported its financial results for the first quarter of 2025, marking a strong start to the year. The Company’s performance highlights…
Perma-Pipe International Holdings Reports Fiscal 2024 Financial Results with Strong Operational Momentum and Strategic Growth Initiatives Nasdaq-listed company achieves significant backlog increase, improved margins, and solid pre-tax earnings in a challenging global environment Perma-Pipe International Holdings,a leading global supplier of…
The Global Pharmaceutical Chemicals Market is projected to see substantial growth over the coming years, with its market value increasing from US$232.4 Billion in 2024 to US$308.9 Billion by 2030. This growth represents a CAGR of 4.9% between 2024 and…
The global specialty carbon black market is poised for significant growth, projected to expand from USD 2.25 billion in 2023 to USD 3.03 billion by 2029, reflecting a compound annual growth rate (CAGR) of approximately 5.06% . Market Overview Specialty…
Bayer Launches Phase I Trial of Actinium-225 Therapy for Liver Cancer Bayer has announced the initiation of a Phase I clinical trial for BAY 3547926 (225Ac-GPC3), an investigational targeted alpha radiopharmaceutical designed to treat advanced hepatocellular carcinoma (HCC) by targeting…
Announces NOV Inc. Reports First Quarter 2025 Results, Demonstrating Resilient Performance Amid Macro Challenges NOV has announced its financial results for the first quarter of 2025, showing a mix of challenges and strong performances. The company generated revenues of $2.10…
Plastec Technologies, a company specializing in industrial technologies, has recently reported its audited financial results for the fiscal year ended December 31, 2024. As the company continues to navigate through its restructuring and simplification processes, the released financial statements reflect…
Merck to Acquire SpringWorks Therapeutics to Strengthen its Healthcare Business and Drive Sustainable Growth Merck, a leading global science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company based in Stamford, Connecticut, today announced they have…
Eastman Delivers Resilient Performance in First Quarter of 2025 Amid Macroeconomic Uncertainty Eastman Chemical Company announced its financial results for the first quarter of 2025, highlighting robust performance despite a complex and uncertain global economic environment. Mark Costa, Chair of…